Cannabidiol or CBD has been one of the many groundbreaking compounds in the cannabis plant for some time now. With a massive amount of research being done which helps digs into the wide variety of potential with using CBD, it seems like the market on the medicine is just now being tapped into.

One of the largest appeals for CBD as a health benefit comes from the fact that it does not contain any psychoactive ingredients. Unlike the compound THC or tetrahydrocannabinol, CBD does not get the user high, thus providing only the medicinal benefits to the patient. If one takes a few drops of CBD for a medicinal purpose, the user would be able to get all of the medicinal benefits of cannabis without the high. This is part of the reason that CBD is legal in many states that cannabis and THC is not.

According to a report done on the substance, growers and scientists have been performing massive amounts of research on the compound to help better understand how it can be used to treat a wide variety of diseases. Stuart W. Titus, the CEO of Medical Marijuana inc. which produces various CBD oils for the broad market, stated that “some people do want the high of course, but others are looking for the health and wellness benefits.” This is exactly where CBD comes in.

Many of the individuals who want to enjoy the benefits of cannabis such as pain relief, anti-anxiety, anti inflammatory and more, often cannot get high throughout their day to day life. With CBD, the user can get many of the medicinal benefits of the entire plant without ever getting a high from it. Because of this, many companies have begun to experiment with the production of CBD based pharmaceuticals to treat everything from cancer-related side effects to seizures and pain control.

CBD has been a large player in the world of epilepsy, where the most popular treatment has been through the use of harsh prescription drugs with a massive amount of side effects. With CBD, patients with epilepsy have often called it a miracle drug due to its ability to control seizures without offering the side effects that traditional seizure drugs do.

According to one report “Cannabidiol (CBD) is just one of over 85 cannabinoids presently identified in the cannabis plant and is the second most abundant cannabinoid in marijuana after THC. In hemp, however, THC is only present in trace amounts, while CBD dominates the plant’s makeup. CBD interacts with our naturally occurring systems, but is non-psychotropic, it doesn’t cause a high. This makes it a safer, less controversial alternative, while still offering significant health benefits.” Although CBD is not a replacement for the medical use of cannabis, it can often be a great alternative to the traditional use of the plant for medicinal reasons. The chemical CBD is one of many that are present in the plant, but it accounts for 40% of the extraction of the chemicals within cannabis. Because of this, deriving oil from cannabis can often be one of the best treatments for many different ailments.

While the use of cannabis is still illegal in many states throughout the country, CBD is legal in many parts of the U.S. that have outlawed cannabis. While THC, the psychoactive component in cannabis can only be fully derived from the cannabis plant, CBD can be taken from the industrial hemp plant, which is legal throughout the U.S. As the market on cannabis continues to grow, the hopes are high that CBD will continue to play a large role in the development of cannabis as a treatment for a series of different ailments in patients around the country.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

*UPDATED* Timing in Marijuana Stocks is Everything & Our Time is Tuesday February 18, 2020, @ 9:45 am EST!

Tuesday, February 18, 2020, @ 9:45 am EST we will be announcing…

Marijuana Stocks – The Current State of the Cannabis Sector from the Wolf of Weed Street aka Jason Spatafora

The Current State of the Cannabis Sector As we’ve begun 2020 after…